.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A small case series explored secondary intrascleral intraocular lens fixation in aphakic eyes with pseudoexfoliation syndrome after challenges with conventional capsular support. Three patients underwent a double-needle intrascleral fixation technique with preservation of the capsule where feasible. Good IOL fixation was achieved in all reported cases, and no serious complications such as retinal detachment or vitreous hemorrhage were observed during the reported follow-up. The value of this publication is less about proving superiority and more about illustrating a reconstructive option when zonular weakness prevents stable in-the-bag fixation. For surgeons encountering an aphakic eye after complicated cataract extraction, secondary IOL planning requires consideration of residual capsule, scleral integrity, iris anatomy, vitreous status, and surgeon familiarity with the fixation technique. Capsule-preserving strategies may help reduce vitreous prolapse and unwanted lens movement, but the authors appropriately emphasize that longer-term risks need further study. This makes the technique particularly relevant for advanced secondary-IOL instruction, where understanding decision pathways may be more important than memorizing a single fixation method.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A small case series explored secondary intrascleral intraocular lens fixation in aphakic eyes with pseudoexfoliation syndrome after challenges with conventional capsular support. Three patients underwent a double-needle intrascleral fixation technique with preservation of the capsule where feasible. Good IOL fixation was achieved in all reported cases, and no serious complications such as retinal detachment or vitreous hemorrhage were observed during the reported follow-up. The value of this publication is less about proving superiority and more about illustrating a reconstructive option when zonular weakness prevents stable in-the-bag fixation. For surgeons encountering an aphakic eye after complicated cataract extraction, secondary IOL planning requires consideration of residual capsule, scleral integrity, iris anatomy, vitreous status, and surgeon familiarity with the fixation technique. Capsule-preserving strategies may help reduce vitreous prolapse and unwanted lens movement, but the authors appropriately emphasize that longer-term risks need further study. This makes the technique particularly relevant for advanced secondary-IOL instruction, where understanding decision pathways may be more important than memorizing a single fixation method.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
